Adagio Medical Holdings (ADGM) Common Equity (2023 - 2026)

Adagio Medical Holdings has disclosed Common Equity across 4 years of filings, most recently posting -$415000.0 for Q2 2026.

• In Q2 2026, Common Equity fell 104.79% year-over-year to -$415000.0; the TTM figure through Jun 2026 stood at -$415000.0 (down 104.79% YoY), while the FY2025 annual figure was $12.4 million, down 37.72% from the prior year.
• Common Equity came in at -$415000.0 for Q2 2026 at Adagio Medical Holdings, down from $5.7 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $76.6 million in Q3 2024 to a low of -$140.5 million in Q2 2024.
• Average Common Equity over 4 years is -$33.4 million, with a median of $2.7 million recorded in 2026.
• Year-over-year, Common Equity jumped 161.99% in 2024 and sank 104.79% in 2026.
• Over 4 years, Common Equity stood at -$132.0 million in 2023, then surged by 115.08% to $19.9 million in 2024, then tumbled by 37.72% to $12.4 million in 2025, then tumbled by 103.35% to -$415000.0 in 2026.
• Per Business Quant data, the three most recent Common Equity figures were -$415000.0 in Q2 2026, $5.7 million in Q1 2026, and $12.4 million in Q4 2025.